Postgraduate Course

Hepatitis C Drug Therapy: Is There Still a Role for Hepatologists?

Speaker(s)

• 

  Paul Kwo, MD, FACG

  Professor of Medicine
  Stanford University
  Redwood City, CA, US

  Advisory Committee/Board Member: AbbVie, Gilead
  Grant/Research Support: AbbVie, BMS, Gilead
  Data and Safety Monitoring Board: Janssen

Learning Objectives:

• Recognize the current state of hepatitis C therapy and the role of the hepatologist.